Colorectal cancer: open trials in Spain

149 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT04929223
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Trial Treatment · Phase 1 · Hoffmann-La Roche
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Donostia, Donostia · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Clinico Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-06
NCT06324357
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Trial Treatment · Phase 1/2 · Boehringer Ingelheim
Complejo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Hospital del Mar, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Duran i Reynals, L'Hospitalet de Llobregat · Clinica Universidad de Navarra Madrid, Madrid · CIO Clara Campal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Fundación Jiménez Díaz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Virgen de la Macarena, Seville · Instituto Valenciano de Oncologia, Valencia
Registry updated 2026-11-05
NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Trial Treatment · Phase 3 · Summit Therapeutics
A Coruña · Barcelona · Córdoba · Granada · Madrid · Málaga · Palma de Mallorca · Santander · Seville · Valencia
Registry updated 2026-11-05
NCT07318805
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-05
NCT07549412
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Trial Treatment · Phase 3 · EMD Serono Research & Development Institute, Inc.
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Virgen De Valme, Sevilla · Instituto Valenciano de Oncología (IVO), Valencia
Registry updated 2026-11-05
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Trial Treatment · Phase 2 · Jazz Pharmaceuticals
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Insular Gran Canarias, Las Palmas · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Regional Universitario de Malaga - Hospital General, Málaga · Complejo Hospitalario de Navarra, Pamplona · INCLIVA-Hospital Clínico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Instituto Oncologico Dr. Rosell S.L. | Oncologia, Barcelona · Hospital Universitari Vall D Hebron | Oncologia Medica, Barcelona · Institut Catala D'oncologia | Hospitalet | Oncologia, L'Hospitalet de Llobregat · Clinica Universidad De Navarra | Madrid | Oncologia, Madrid · Hospital Universitario Fundacion Jimenez Diaz | Oncologia Medica, Madrid
Registry updated 2026-11-04
NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Clínico San Carlos, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Central De Asturias, Oviedo · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-11-04
NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Quiron Dexeus Barcelona, Barcelona · South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
Registry updated 2026-11-04
NCT05379595
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT05856981
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Sairopa B.V.
Hosp 12 de Octubre, Madrid · Hospital General Universitario Gergorio Maranon, Madrid
Registry updated 2026-11-03
NCT06662786
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Ramón y Cajal, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Clinica Universidad de Navarra, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT06663319
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario HM Sanchinarro, Madrid
Registry updated 2026-11-03
NCT06750094
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Universitario de Badajoz, Badajoz · Hospital del Mar, Barcelona · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Instituto Multidisciplinar De Oncologia S.A., Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clinica Universidad de Navarra, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Regional de Málaga, Málaga · Clínica Universidad de navarra, Pamplona · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Genmab
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario de Navarra, Pamplona · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-11-02
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Hospital Clinic Barcelona, Barcelona · START Barcelona, Barcelona · START Rioja - Hospital de San Pedro, Logroño · NEXT Madrid HUQSM, Madrid · Hospital Universitari Son Espases, Palma · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-30
NCT07284849
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Trial Treatment · Phase 3 · Incyte Corporation
Hospital Germans Trias i Pujol, Badalona · Hospital Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Hospital Son Espases, Palma · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitari Mutua Terrassa, Terrassa · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-30
NCT06428409
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Central De Asturias, Oviedo
Registry updated 2026-10-29
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Trial Treatment · Phase 1 · Astellas Pharma Inc
Barcelona · Madrid · Madrid
Registry updated 2026-10-29
NCT04421820
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
Trial Treatment · Phase 1/2 · Bold Therapeutics, Inc.
Vall d'Hebron Institute of Oncology, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-10-28
NCT06820463
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Trial Treatment · Phase 2 · AbbVie
Hospital Universitari Vall d'Hebron, Barcelona · Clinica Universidad de Navarra, Madrid · Hospital Universitario La Paz, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-27
NCT07808151
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Trial Treatment · Phase 2 · Solstice Oncology, Inc.
Barcelona · L'Hospitalet de Llobregat · Madrid
Registry updated 2026-10-27
2026-525883-17-00
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
Trial Treatment · Phase 3 · Genmab A/S
Institut Catala d'Oncologia, Badalona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Micancer Center S.L.P., Barcelona · Hospital del Mar, Barcelona · Hospital Universitario del Vinalopo, Elche · Hospital General Universitario de Elche, Elche · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Regional de Málaga, Málaga · Clínica Universidad de navarra, Pamplona · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario de Torrejon, Torrejón de Ardoz · Consorcio Hospital General Universitario de Valencia, Valencia · Fundación Instituto Valenciano de Oncología, Valencia · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-10-26

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error